The Dodd-Frank Act dramatically transformed the bank industry when it was passed in 2010. But fast forward to today and President Trump is promising to make it a thing of the past. On this week's episode of Industry Focus, Gaby and John provide a comprehensive look at not only the history and purpose of Dodd-Frank, but also how it might be reformed.

We explain why Facebook and Shopify are two tech stocks we really like, and answer Gaby's questions about the companies.

Thanks to Audible for supporting our podcast. Get a free audiobook with a free 30 day trial at audible.com/fool.

There are many green stocks in the marketplace, here are two of the top plays today.

Thanks to Thumbtack for supporting Motley Fool. Hire local, skilled pros for just about anything at thumbtack.com today.

 These companies are disrupting their respective industries, and each has catalysts that could reward investors in the future. Is one a better stock to buy than the other?

Thanks to Audible for supporting our podcast. Get a free audiobook with a free 30 day trial at audible.com/fool.

We welcome financials analyst Gaby Lapera to the show to share some of our favorite stocks in the consumer and retail sector. In this case, leading companies in their respective industries can still make for a David and Goliath story. 

Thanks to Thumbtack for supporting Motley Fool. Hire local, skilled pros for just about anything at thumbtack.com today.

Listen as two great stocks in the financials sector face off against each other.

Apple's recent quarterly check-ins have been fairly ho-hum, but not this time! The Mac maker is back to growth after an impressive quarter, we explain what segments pushed the company over the top, and what investors can expect next quarter.

Forget that power plant off in the distance, these places have wind mills present on the horizon.

Competitors make headway against Teva Pharmaceutical's top-seller, and Biogen's hemophilia drugs become Bioverativ. Here's what you should know.